Pristanic acid

• Description :

  Pristanic acid is an endogenous metabolite present in Blood that can be used for the research of Alpha Methylacyl CoA Racemase Deficiency and Zellweger Syndrome[1][2][3].

• UNSPSC :

  12352211

• Hazard Statement :

  H315, H319

• Target :

  Endogenous Metabolite

• Type :

  Natural Products

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Metabolism-sugar/lipid metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/Pristanic_acid.html

• Purity :

  99.94

• Solubility :

  DMSO : 50 mg/mL (ultrasonic)

• Smiles :

  CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O

• Molecular Formula :

  C19H38O2

• Molecular Weight :

  298.50

• Precautions :

  H315, H319

• References & Citations :

  [1]McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar;72 (3) :396-9.|[2]Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov;44 (5) :720-30. |[3]Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39 (35) :5709-5720.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• Isoform :

  Human Endogenous Metabolite

• CAS Number :

  [1189-37-3]